2017 International Congress Archives - Page 18 of 155

1:15pm-2:45pm: Focused ultrasound subthalamotomy for Parkinson’s disease: A pilot study

R. Martinez-Fernandez, R. Rodriguez-Rojas, M. del Álamo, F. Hernandez, J.A. Pineda-Pardo, M. di Leone, F. Alonso, I. Obeso, C. Gasca-Salas, E. de Luis, L. Vela, J.A. Obeso (Mostoles, Spain)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Four year outcomes of a prospective, multi-center trial evaluating Deep Brain Stimulation with a new multiple-source, constant-current rechargeable system in Parkinson’s disease

L. Timmermann, R. Jain, N. Van Dyck, L. Chen, T. Brücke, F. Seijo, E. San Martin, V. Visser-Vandewalle, M. Barbe, S. Gill, A. Whone, M. Porta, D. Servello, F. Alesch (Cologne, Germany)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Functional Connectivity Differences Across Parkinson Disease Subtypes

M. Campbell, C. Gratton, J. Koller, W. Shannon, C. Lessov-Schlaggar, S. Petersen, J. Perlmutter (St. Louis, MO, USA)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Functional MAOB gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson’s disease

M. Löhle, G. Mangone, M. Wolz, B. Beuthien-Baumann, L. Oehme, J. Hoff, J. Kotzerke, H. Reichmann, J.-C. Corvol, A. Storch (Rostock, Germany)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Functional role of the cerebellum in Parkinson’s disease : a PET-Study

A. Riou, F. Le Jeune, J.-F. Houvenaghel, S. Drapier, M. Vérin, G. Robert (RENNES, France)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Gait and Balance Impairment After Methanol Intoxication

K. Peterová, H. Brožová, J. Klempíř, I. Lišková, S. Zakharov, O. Bezdíček, M. Vaněčková, Z. Seidl, E. Růžička (Prague, Czech Republic)

Other · Exhibit Hall C

1:15pm-2:45pm: Gait asymmetry and asymmetry index in a sample of patients with PD and control group in Cali – Colombia.

B. Munoz, A. Enriquez-Marulanda, J. Orozco (Cali, Colombia)

Other · Exhibit Hall C

1:15pm-2:45pm: Gait Asymmetry and Parkinson’s Disease

C. Ashton, L. Solis-Cohen, L. Wagenaar, R. Laracuente, E. Sorberg, V. Vanderhorst, L. Shih (Boston, MA, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Gait asymmetry in people with Parkinson’s disease is linked to reduced integrity of callosal sensorimotor regions

F. Horak, C. Curtze, B. Fling (Portland, OR, USA)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Global Regulatory Agencies Support the Use of Dopamine Transporter Neuroimaging for Subject Selection in Clinical Trials Targeting Early Stage Parkinson’s Disease – on behalf of Critical Path for Parkinson’s (CPP) Consortium

D. Stephenson, J. Cedarbaum, J. Eberling, M. Facheris, D. Grosset, M. Gordon, D. Hill, S. Imam, V. Kern, G. Klein, D. Matthews, P. Muglia, A. Roach, K. Romero, D. Russell, J. Seibyl, L. Slieker, E. Somer, C. Sur, Z. Xie, K. Marek (Tucson, AZ, USA)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C